GRPR and neoplasm: In fact, several reports have described the effect of selective GRPR antagonists on inhibition of tumor growth in numerous models, including prostate cancer cell lines (PC-3, DU-145, MDA-PCa-2b) [14-16], although the associated mechanisms are not yet completely understood.